MALIGNANT NEOPLASM OF UTERUS

Clinical trials for MALIGNANT NEOPLASM OF UTERUS explained in plain language.

Never miss a new study

Get alerted when new MALIGNANT NEOPLASM OF UTERUS trials appear

Sign up with your email to follow new studies for MALIGNANT NEOPLASM OF UTERUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New Two-Drug attack on recurrent Women's cancers

Disease control Recruiting now

This study aims to find the safest and most effective dose of a new drug, sacituzumab govitecan, when combined with an existing chemotherapy drug, cisplatin. It is for women whose ovarian or endometrial cancer has returned but responded well to platinum-based chemotherapy in the …

Matched conditions: MALIGNANT NEOPLASM OF UTERUS

Phase: PHASE1, PHASE2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control

Last updated Mar 23, 2026 15:20 UTC

MALIGNANT NEOPLASM OF UTERUS

Get alerted when new MALIGNANT NEOPLASM OF UTERUS trials appear

New Two-Drug attack on recurrent Women's cancers